Evoke Pharma, Inc. (NASDAQ:EVOK)

About the company

Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

5

CEO

David A. Gonyer

Exchange

NASDAQ

Website

http://www.evokepharma.com

$397.00M

Total Revenue

5

Employees

$85.44M

Market Capitalization

-12.71

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$0M

Operating Margin (in %)

Total operating margin

$-19M

Net Margin (in %)

Total net margin

$-3M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Catalent, Inc. CTLT 12377.43 2872.00 6.22 118.67 3.63
Horizon Therapeutics Plc HZNP 11924.85 1376.00 5.08 18.80 43.06
Perrigo Co. Plc PRGO 7959.70 4837.00 1.36 54.30 3.02
Bausch Health Cos., Inc. BHC 6583.45 8597.00 9.19 -3.48 -21.96
Jazz Pharmaceuticals Plc JAZZ 6239.22 2188.00 2.16 22.80 12.81
United Therapeutics Corp. UTHR 5208.59 1443.00 1.81 10.05 36.59
MyoKardia, Inc. MYOK 4337.34 34.00 12.61 -13.99 -201.73
Axsome Therapeutics, Inc. AXSM 2873.15 None 19.50 -31.94 None
Pacira Biosciences, Inc. PCRX 2414.16 435.00 6.47 -5748.00 -0.02
SAGE Therapeutics, Inc. SAGE 2353.00 9.00 2.77 -3.63 -413.06
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
Prestige Consumer Healthcare, Inc. PBH 2006.85 963.00 1.69 14.15 14.77
Corcept Therapeutics, Inc. CORT 1984.94 335.00 4.56 18.70 31.64
Ironwood Pharmaceuticals, Inc. IRWD 1624.95 440.00 -23.00 19.17 19.14
Innoviva, Inc. INVA 1596.69 285.00 3.78 8.26 66.41
Madrigal Pharmaceuticals, Inc. MDGL 1558.95 0.00 4.16 -15.26 -624.74
Revolution Medicines, Inc. RVMD 1534.59 48.00 3.98 -21.68 -146.29
Intercept Pharmaceuticals, Inc. ICPT 1431.04 272.00 -42.59 -4.17 -127.53
Supernus Pharmaceuticals, Inc. SUPN 1346.76 402.00 2.14 11.55 28.90
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Zogenix, Inc. ZGNX 1321.20 5.00 3.61 -3.11 -241.62
Theravance Biopharma, Inc. TBPH 1255.14 88.00 -8.81 -5.09 -280.80
Revance Therapeutics, Inc. RVNC 1153.38 0.00 4.55 -6.18 41.82
Amphastar Pharmaceuticals, Inc. AMPH 996.17 327.00 2.49 19.55 15.90
BellRing Brands, Inc. BRBR 805.74 954.00 -0.44 6.11 13.98
Endo International Plc ENDP 775.20 3014.00 -1.06 -2.76 -9.09
Eagle Pharmaceuticals, Inc. EGRX 711.20 192.00 3.82 282.22 1.29
Assembly Biosciences, Inc. ASMB 684.40 16.00 3.07 -6.88 -601.75
Aerie Pharmaceuticals, Inc. AERI 629.28 79.00 4.99 -3.11 -252.92
Collegium Pharmaceutical, Inc. COLL 590.24 299.00 4.22 -45.68 -4.21
Intersect ENT, Inc. XENT 576.80 102.00 5.45 -11.55 -48.61
Catalyst Pharmaceuticals, Inc. CPRX 543.56 119.00 5.29 12.39 36.09
Anika Therapeutics, Inc. ANIK 529.20 125.00 1.83 19.09 22.73
BioDelivery Sciences International, Inc. BDSI 414.92 130.00 5.93 -56.38 -5.01
ANI Pharmaceuticals, Inc. ANIP 354.72 203.00 1.81 -227.38 -0.67
Albireo Pharma, Inc. ALBO 309.92 11.00 3.15 -4.05 -730.55
MEI Pharma, Inc. MEIP 290.50 5.00 5.00 -7.45 -539.48
Mallinckrodt Plc MNK 260.40 3037.00 0.14 -0.22 -39.56
Agile Therapeutics, Inc. AGRX 149.86 None 2.44 -7.26 None
Cerecor, Inc. CERC 118.68 7.00 7.59 -5.27 -429.22
Marinus Pharmaceuticals, Inc. MRNS 115.92 0.00 5.26 -1.72 None
Ampio Pharmaceuticals, Inc. AMPE 92.95 1.00 65.00 -5.00 None
AcelRx Pharmaceuticals, Inc. ACRX 86.40 2.00 -1.59 -1.54 -644.25
Evoke Pharma, Inc. EVOK 85.44 397.00 29.67 -12.71 -0.76
Aclaris Therapeutics, Inc. ACRS 83.23 4.00 1.46 -0.60 None
Zynerba Pharmaceuticals, Inc. ZYNE 81.88 0.00 1.34 -2.28 -699.94
CTI BioPharma Corp. CTIC 81.42 3.00 3.63 -1.97 -111.83
Oramed Pharmaceuticals, Inc. ORMP 77.14 3.00 2.80 -7.12 -398.34
Adamas Pharmaceuticals, Inc. ADMS 75.04 57.00 -4.79 -0.81 -160.44
Cassava Sciences, Inc. SAVA 64.41 41.00 3.39 -14.13 76.71
Acasti Pharma, Inc. ACST 58.65 0.00 4.93 -2.30 -611.47
Natural Alternatives International, Inc. NAII 50.26 114.00 0.69 -13.30 -3.19
Cumberland Pharmaceuticals, Inc. CPIX 49.35 47.00 1.00 -10.97 -9.59
SCYNEXIS, Inc. SCYX 46.92 0.00 9.86 -1.21 -30.84
IsoRay, Inc. ISR 42.21 9.00 7.87 -12.60 -36.08
Lipocine, Inc. LPCN 38.70 0.00 9.21 -2.58 None
Neos Therapeutics, Inc. NEOS 31.75 65.00 -2.44 -1.81 -26.74
PLx Pharma, Inc. PLXP 25.74 0.00 -2.47 -2.72 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 20.64 3.00 2.57 -1.74 -264.21
Regulus Therapeutics, Inc. RGLS 16.38 0.00 1.44 -0.76 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.30 8.00 0.66 -0.15 -798.18
Intec Pharma Ltd. NTEC 11.47 None 1.48 -0.26 None
Hepion Pharmaceuticals, Inc. HEPA 10.02 None 1.77 3.01 None
Sonoma Pharmaceuticals, Inc. SNOA 6.61 19.00 1.50 -3.32 -15.56
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
VIVUS, Inc. VVUS 5.72 73.00 -0.13 -0.19 -39.28
Tonix Pharmaceuticals Holding Corp. TNXP 3.99 None 1.00 -0.08 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Evoke Pharma Initiates Commercial Manufacturing of Gimoti™

1d ago, source: YAHOO!

SOLANA BEACH, Calif., July 15, 2020 -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today.

Evoke Pharma Extends Cash Runway to 2Q 2021

8d ago, source: Business Insider

The partnership with EVERSANA has allowed us avoid significant capital investment by leveraging their infrastructure, expertise and financial resources for this product launch.” About Evoke Pharma, ...

Evoke Pharma Inc.

6d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Evoke Pharma Initiates Commercial Manufacturing of Gimoti

1d ago, source: wallstreet online

We have continued to accelerate the necessary pre-commercialization activities for Gimoti alongside our commercial and manufacturing partners,” said David Gonyer, R.Ph., President and CEO. “Together ...

Evoke Pharma Extends Cash Runway to 2Q 2021

8d ago, source: YAHOO!

SOLANA BEACH, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that ...

Evoke Pharma Extends Cash Runway to 2Q 2021

8d ago, source: Stockhouse

SOLANA BEACH, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced ...

BRIEF-Evoke Pharma Extends Cash Runway To 2Q 2021

7d ago, source: Reuters

EVOKE PHARMA EXTENDS CASH RUNWAY TO 2Q 2021 * EVOKE PHARMA INC - AS OF JUNE 30, 2020 IT HAD CASH AND CASH EQUIVALENTS OF ABOUT $8.0 MILLION ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.